CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Millions |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Revenues | ||||
| Total Revenues | $ 1,737.3 | $ 1,537.6 | $ 5,323.6 | $ 4,871.9 |
| Expenses | ||||
| Compensation and benefits | 234.3 | 237.6 | 690.8 | 665.9 |
| Technology | 80.9 | 71.4 | 240.8 | 208.0 |
| Professional fees and outside services | 31.1 | 36.7 | 88.4 | 102.6 |
| Amortization of purchased intangibles | 56.0 | 56.2 | 168.1 | 167.5 |
| Depreciation and amortization | 27.4 | 26.4 | 82.8 | 81.0 |
| Licensing and other fee agreements | 104.2 | 81.6 | 320.1 | 274.4 |
| Other | 62.0 | 55.1 | 174.4 | 162.6 |
| Total Expenses | 595.9 | 565.0 | 1,765.4 | 1,662.0 |
| Operating Income | 1,141.4 | 972.6 | 3,558.2 | 3,209.9 |
| Non-Operating Income (Expense) | ||||
| Investment income | 1,418.1 | 1,548.7 | 4,237.1 | 3,959.8 |
| Interest and other borrowing costs | (43.5) | (44.0) | (130.7) | (129.7) |
| Equity in net earnings of unconsolidated subsidiaries | 102.8 | 96.3 | 302.9 | 283.5 |
| Other non-operating income (expense) | (1,264.0) | (1,396.6) | (3,774.1) | (3,571.4) |
| Total Non-Operating Income (Expense) | 213.4 | 204.4 | 635.2 | 542.2 |
| Income before Income Taxes | 1,354.8 | 1,177.0 | 4,193.4 | 3,752.1 |
| Income tax provision | 317.9 | 269.0 | 960.4 | 862.8 |
| Net Income | $ 1,036.9 | $ 908.0 | $ 3,233.0 | $ 2,889.3 |
| Earnings per Share Attributable to Common Shareholders of CME Group: | ||||
| Basic (in dollars per share) | $ 2.90 | $ 2.49 | $ 9.00 | $ 7.93 |
| Diluted (in dollars per share) | $ 2.89 | $ 2.49 | $ 8.96 | $ 7.92 |
| Weighted Average Number of Common Shares: | ||||
| Basic (in shares) | 358,019 | 359,686 | 359,336 | 359,653 |
| Diluted (in shares) | 358,641 | 360,422 | 361,018 | 360,330 |
| Clearing and transaction fees | ||||
| Revenues | ||||
| Total Revenues | $ 1,378.1 | $ 1,227.9 | $ 4,273.2 | $ 3,953.2 |
| Market data and information services | ||||
| Revenues | ||||
| Total Revenues | 243.1 | 202.5 | 705.3 | 595.1 |
| Other | ||||
| Revenues | ||||
| Total Revenues | $ 116.1 | $ 107.2 | $ 345.1 | $ 323.6 |
| X | ||||||||||
- Definition Licensing Fees No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expenses incurred in the period for information technology and data processing products and services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|